Cytek Biosciences
CTKB
CTKB
165 hedge funds and large institutions have $372M invested in Cytek Biosciences in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 51 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.37% more ownership
Funds ownership: 64.15% → 66.53% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $414M → $372M (-$42.5M)
Holders
165
Holding in Top 10
2
Calls
$71K
Puts
$24K
Top Buyers
| 1 | +$7.27M | |
| 2 | +$3.75M | |
| 3 | +$3.45M | |
| 4 |
SC
Simcoe Capital
Spokane,
Washington
|
+$2.76M |
| 5 |
Goldman Sachs
New York
|
+$2.62M |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$2.8M | |
| 3 | -$1.78M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.29M |
